Provention Bio Inc. Shares Close the Week 20.3% Lower - Weekly Wrap

The company saw its shares close the week 20.3% lower than last week, with trading volume higher than its 30 day average.

Mar 26, 2021 by Kwhen Finance Editors

Provention Bio Inc. Shares Close the Week 20.3% Lower - Weekly Wrap
Provention Bio Inc. shares closed this week 20.3% lower than it did at the end of last week. The stock is currently down 36.8% year-to-date, up 28.1% over the past 12 months, and up 122.5% over the past five years. This week, the Dow Jones Industrial Average rose 1.4%, and the S&P 500 rose 1.7%.

Trading Activity

  • Shares traded as high as $13.87 and as low as $10.47 this week.
  • Shares closed 5e+1% below its 52-week high and 4e+1% above its 52-week low.
  • Trading volume this week was 1.9% lower than the 10-day average and 3.6% higher than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
  • MACD, a trend-following momentum indicator, indicates a downward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.

Market Comparative Performance

  • The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and beats it on a 5-year basis
  • The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and beats it on a 5-year basis
  • The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and beats it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Provention Bio Inc.-6.6-36.828.1-42.555.7
Dow Jones Industrial Average1.48.655.8-1.461.3
S&P 500 Index1.66.358.8-1.562.9
Health Care1.93.041.6-3.841.1

Peer Group Comparative Performance

  • The company's stock price performance year-to-date lags the peer average by -392.6%
  • The company's stock price performance over the past 12 months lags the peer average by -96.7%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Provention Bio Inc.PRVB0-36.828.1-42.555.7
Peer AvgN/A-2.012.6853.7-26.31069.4
Outlook Therapeutics Inc.OTLK-8.073.8264.5-46.0310.8
Organovo Holdings Inc.ONVO0-23.53150.4-59.23966.7

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: